• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳青霉烯类抗生素节约方案治疗重症监护病房产碳青霉烯酶肺炎克雷伯菌感染

Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit.

机构信息

Fondazione Toscana Gabriele Monasterio, Azienda Ospedaliera Universitaria Pisana, Italy.

出版信息

Clin Infect Dis. 2013 Mar;56(5):697-700. doi: 10.1093/cid/cis969. Epub 2012 Nov 15.

DOI:10.1093/cid/cis969
PMID:23155147
Abstract

A carbapenem-sparing regimen of tigecycline plus gentamicin or colistin was effective for treating 24 of 26 (92%) Klebsiella pneumoniae carbapenemase-producing K. pneumoniae infectious episodes in 22 polytrauma intensive care unit patients without comorbidities. The 30-day crude mortality rate was 14%. Regimens were considered appropriate in 12% of episodes according to the Vitek 2 System and in 100% based on E-test.

摘要

碳青霉烯类抗生素节约方案的替加环素联合庆大霉素或黏菌素对 22 名无合并症的多发创伤重症监护病房患者中的 26 例(92%)产碳青霉烯酶肺炎克雷伯菌感染的治疗是有效的,其中 24 例有效。30 天粗死亡率为 14%。根据 Vitek 2 系统,12%的病例认为方案合适,根据 E 试验则为 100%。

相似文献

1
Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit.碳青霉烯类抗生素节约方案治疗重症监护病房产碳青霉烯酶肺炎克雷伯菌感染
Clin Infect Dis. 2013 Mar;56(5):697-700. doi: 10.1093/cid/cis969. Epub 2012 Nov 15.
2
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda.产 KPC 碳青霉烯酶肺炎克雷伯菌感染的关键问题:一个关键议程。
Future Microbiol. 2015;10(2):283-94. doi: 10.2217/fmb.14.121.
3
Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin.一名年轻成人患耐碳青霉烯类肺炎克雷伯菌心内膜炎。庆大霉素和黏菌素治疗成功。
Int J Infect Dis. 2009 Sep;13(5):e295-8. doi: 10.1016/j.ijid.2009.01.006. Epub 2009 Mar 28.
4
Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria.重症监护病房感染泛耐药和广泛耐药碳青霉烯酶-producing 革兰氏阴性菌的患者使用磷霉素治疗的结果。
Int J Antimicrob Agents. 2014 Jan;43(1):52-9. doi: 10.1016/j.ijantimicag.2013.09.010. Epub 2013 Oct 16.
5
Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.用于产碳青霉烯酶肺炎克雷伯菌的三联抗生素联合疗法:一项系统评价
Ann Clin Microbiol Antimicrob. 2017 Nov 25;16(1):76. doi: 10.1186/s12941-017-0249-2.
6
An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.希腊某大学医院产碳青霉烯酶肺炎克雷伯菌β-内酰胺酶 2 的肺炎克雷伯菌感染暴发:分子特征、流行病学和结局。
Clin Infect Dis. 2010 Feb 1;50(3):364-73. doi: 10.1086/649865.
7
Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation.实体器官移植中感染产肺炎克雷伯菌碳青霉烯酶(KPC)的肺炎克雷伯菌。
Transpl Infect Dis. 2012 Apr;14(2):198-205. doi: 10.1111/j.1399-3062.2011.00688.x. Epub 2011 Oct 28.
8
Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia.产碳青霉烯酶的泛耐药肺炎克雷伯菌菌血症的成功治疗
Antimicrob Agents Chemother. 2015 Oct;59(10):5903-8. doi: 10.1128/AAC.00655-15.
9
Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.高产碳青霉烯酶耐药肺炎克雷伯菌引起的粘菌素耐药菌血症相关死亡率:不使用粘菌素和碳青霉烯类药物联合治疗的重要性。
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00406-17. Print 2017 Aug.
10
Emergence of tigecycline- and carbapenem-nonsusceptible Klebsiella pneumoniae ST11 clone in patients without exposure to tigecycline.耐替加环素和碳青霉烯类药物的肺炎克雷伯菌 ST11 克隆在未接触替加环素的患者中的出现。
J Microbiol Immunol Infect. 2016 Dec;49(6):962-968. doi: 10.1016/j.jmii.2015.10.014. Epub 2015 Nov 19.

引用本文的文献

1
Evaluating tigecycline dosing for hospital-acquired pneumonia patients: insights from physiologically-based pharmacokinetic modeling of lung exposure.评估替加环素对医院获得性肺炎患者的给药方案:基于肺暴露的生理药代动力学模型的见解
Antimicrob Agents Chemother. 2025 Jul 2;69(7):e0000425. doi: 10.1128/aac.00004-25. Epub 2025 May 20.
2
Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections.耐碳青霉烯类肠杆菌科细菌感染的抗菌治疗指南
Infect Chemother. 2024 Sep;56(3):308-328. doi: 10.3947/ic.2024.0038. Epub 2024 Aug 2.
3
Antibiotic Therapy Strategies for Treating Gram-Negative Severe Infections in the Critically Ill: A Narrative Review.
治疗危重症患者革兰阴性菌严重感染的抗生素治疗策略:一篇叙述性综述
Antibiotics (Basel). 2023 Jul 31;12(8):1262. doi: 10.3390/antibiotics12081262.
4
Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality.十年耐碳青霉烯类肺炎克雷伯菌血流感染经验:早期恰当经验性治疗对死亡率的影响
Biomedicines. 2022 Dec 16;10(12):3268. doi: 10.3390/biomedicines10123268.
5
Tigecycline and Gentamicin-Combined Treatment Enhances Renal Damage: Oxidative Stress, Inflammatory Reaction, and Apoptosis Interplay.替加环素与庆大霉素联合治疗加重肾损伤:氧化应激、炎症反应与细胞凋亡的相互作用
Pharmaceuticals (Basel). 2022 Jun 10;15(6):736. doi: 10.3390/ph15060736.
6
Evaluation of the Therapeutic Outcomes of Antibiotic Regimen Against Carbapenemase-Producing : A Systematic Review and Meta-Analysis.针对产碳青霉烯酶菌株的抗生素治疗方案疗效评估:一项系统综述与荟萃分析
Front Pharmacol. 2021 Nov 4;12:597907. doi: 10.3389/fphar.2021.597907. eCollection 2021.
7
Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions.碳青霉烯类耐药肠杆菌科感染的治疗:最新进展和未来方向。
Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2053-2068. doi: 10.1007/s10096-021-04296-1. Epub 2021 Jun 24.
8
Mortality, clinical and microbiological response following antibiotic therapy among patients with carbapenem-resistant infections (a meta-analysis dataset).碳青霉烯类耐药感染患者抗生素治疗后的死亡率、临床及微生物学反应(一项荟萃分析数据集)
Data Brief. 2019 Nov 30;28:104907. doi: 10.1016/j.dib.2019.104907. eCollection 2020 Feb.
9
Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children.儿童碳青霉烯类耐药肠杆菌科感染的治疗。
J Pediatric Infect Dis Soc. 2020 Feb 28;9(1):56-66. doi: 10.1093/jpids/piz085.
10
Carbapenem-resistant Klebsiella pneumonia infection outbreak in a tertiary urology clinic: analysis of influencing factors with a controlled trial.碳青霉烯类耐药肺炎克雷伯菌感染在一家泌尿外科三甲医院的爆发:一项对照试验分析其影响因素。
Turk J Med Sci. 2020 Feb 13;50(1):239-247. doi: 10.3906/sag-1909-46.